Predictors of in-hospital mortality for bloodstream infections caused by Enterobacter species or Citrobacter freundii. (Q51924519)

17 April 2018

title

Predictors of in-hospital mortality for bloodstream infections caused by Enterobacter species or Citrobacter freundii. (English)

1 reference

17 April 2018

0 references

Citrobacter freundii

1 reference

1

1 reference

17 April 2018

Marin H Kollef

6

object named as

Marin H Kollef

1 reference

17 April 2018

Scott T Micek

2

1 reference

17 April 2018

David J Ritchie

3

1 reference

17 April 2018

Richard M Reichley

4

1 reference

17 April 2018

W Michael Dunne

5

1 reference

17 April 2018

language of work or name

English

0 references

publication date

1 February 2007

1 reference

17 April 2018

published in

Pharmacotherapy

1 reference

17 April 2018

volume

27

1 reference

17 April 2018

issue

2

1 reference

17 April 2018

page(s)

191-199

1 reference

17 April 2018

Nosocomial bacteremia caused by antibiotic-resistant gram-negative bacteria in critically ill patients: clinical outcome and length of hospitalization

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.2.191

Overview of nosocomial infections caused by gram-negative bacilli

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.2.191

National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.2.191

National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.2.191

Impact of antibiotic-resistant Gram-negative bacilli infections on outcome in hospitalized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.2.191

Evaluation of outcome in critically ill patients with nosocomial enterobacter bacteremia: results of a matched cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.2.191

Health and economic outcomes of the emergence of third-generation cephalosporin resistance in Enterobacter species

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.2.191

Bloodstream infections caused by Enterobacter species: predictors of 30-day mortality rate and impact of broad-spectrum cephalosporin resistance on outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.2.191

Variations in the prevalence of strains expressing an extended-spectrum beta-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.2.191

Origin and evolution of the AmpC beta-lactamases of Citrobacter freundii

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.2.191

Diversity of chromosomal AmpC beta-lactamases from Enterobacter cloacae isolates in a Portuguese hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.2.191

The relationship between antecedent antibiotic use and resistance to extended-spectrum cephalosporins in group I beta-lactamase-producing organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.2.191

Risk factors for emergence of resistance to broad-spectrum cephalosporins among Enterobacter spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.2.191

Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.2.191

Relationship between ceftriaxone use and resistance to third-generation cephalosporins among clinical strains of Enterobacter cloacae

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.2.191

Use of several inducer and substrate antibiotic combinations in a disk approximation assay format to screen for AmpC induction in patient isolates of Pseudomonas aeruginosa, Enterobacter spp., Citrobacter spp., and Serratia spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.2.191

Antibiotic cost savings from formulary restrictions and physician monitoring in a medical-school-affiliated hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.2.191

A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.2.191

APACHE II: a severity of disease classification system

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.2.191

Outcome of antibiotic therapy for third-generation cephalosporin-resistant Gram-negative bacteraemia: an analysis of 249 cases caused by Citrobacter, Enterobacter and Serratia species

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.2.191

Epidemiological risk factors for isolation of ceftriaxone-resistant versus -susceptible citrobacter freundii in hospitalized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.2.191

Impact of previous use of antibiotics on development of resistance to extended-spectrum cephalosporins in patients with enterobacter bacteremia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.2.191

Treatment with a broad-spectrum cephalosporin versus piperacillin-tazobactam and the risk for isolation of broad-spectrum cephalosporin-resistant Enterobacter species

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.2.191

Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.2.191

The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.2.191

Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.2.191

Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.2.191

Activity of cefepime against ceftazidime-resistant gram-negative bacilli using low and high inocula.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.2.191

Efficacy of cefepime in the treatment of infections due to multiply resistant Enterobacter species

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.2.191

21 January 2018

Identifiers

DOI

10.1592/PHCO.27.2.191

1 reference

17 April 2018

1 reference

17 April 2018